ATP7B and Wilson disease: To examine the effect of genetic correction of the ATP7B R778L mutation with isogenic backgrounds on WD disease modeling, we performed CRISPR-Cas9-based gene correction on one previously generated WD-iPSC line carrying the predominant homozygous mutation (R778L) (17) (Fig. 5A).